Cisplatin is a Intravenous Injection, Solution in the Human Prescription Drug category. It is labeled and distributed by Teva Parenteral Medicines, Inc.. The primary component is Cisplatin.
| Product ID | 0703-5747_20c921dd-8a91-46cd-9c37-03c7396d1bed |
| NDC | 0703-5747 |
| Product Type | Human Prescription Drug |
| Proprietary Name | Cisplatin |
| Generic Name | Cisplatin |
| Dosage Form | Injection, Solution |
| Route of Administration | INTRAVENOUS |
| Marketing Start Date | 2000-06-01 |
| Marketing Category | ANDA / ANDA |
| Application Number | ANDA074656 |
| Labeler Name | Teva Parenteral Medicines, Inc. |
| Substance Name | CISPLATIN |
| Active Ingredient Strength | 50 mg/50mL |
| Pharm Classes | Platinum-based Drug [EPC], Platinum-containing Compounds [EXT] |
| NDC Exclude Flag | N |
| Listing Certified Through | 2023-12-31 |
| Marketing Start Date | 2000-06-01 |
| NDC Exclude Flag | N |
| Sample Package? | N |
| Marketing Category | ANDA |
| Application Number | ANDA074656 |
| Product Type | HUMAN PRESCRIPTION DRUG |
| Billing Unit | ML |
| Marketing Start Date | 2000-06-01 |
| Ingredient | Strength |
|---|---|
| CISPLATIN | 50 mg/50mL |
| SPL SET ID: | a440f077-46f6-4688-a209-65bce38d1c92 |
| Manufacturer | |
| UNII | |
| RxNorm Concept Unique ID - RxCUI | |
| UPC Code |
| NDC | Brand Name | Generic Name |
|---|---|---|
| 0143-9504 | CISplatin | Cisplatin |
| 0143-9505 | CISplatin | Cisplatin |
| 0703-5747 | Cisplatin | Cisplatin |
| 0703-5748 | Cisplatin | Cisplatin |
| 16729-288 | Cisplatin | Cisplatin |
| 44567-509 | CISplatin | CISplatin |
| 44567-510 | CISplatin | CISplatin |
| 44567-511 | CISplatin | CISplatin |
| 44567-530 | Cisplatin | cisplatin |
| 47781-609 | Cisplatin | cisplatin |
| 47781-610 | Cisplatin | cisplatin |
| 63323-103 | Cisplatin | CISPLATIN |
| 68001-283 | Cisplatin | Cisplatin |
| 68083-162 | CISPLATIN | Cisplatin |
| 68083-163 | CISPLATIN | Cisplatin |
| 70860-206 | Cisplatin | cisplatin |
| 61126-003 | Platinol | cisplatin |
| 61126-004 | Platinol-AQ | cisplatin |